Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease

Srikanth Givvimani1, Natia Qipshidze, Neetu Tyagi

  • 1Department of Physiology and Biophysics, University of Louisville School of Medicine Louisville, Kentucky.

Insights

High homocysteine (HHcy) levels cause heart failure by disrupting cell communication and function. Blocking NMDA-R1 receptors with MK-801 shows promise in mitigating these harmful effects and preventing sudden cardiac death.

Area of Science:

  • Cardiovascular Research
  • Molecular Cardiology
  • Biochemistry

Background:

  • Elevated homocysteine (HHcy) is linked to cardiac arrhythmia and sudden cardiac death (SCD).
  • HHcy disrupts cardiac cell function by increasing iNOS, activating MMPs, degrading connexin-43, and altering collagen/elastin ratios.
  • This leads to impaired cardiac conduction and endothelial-myocyte (E-M) uncoupling.

Purpose of the Study:

  • To investigate the mechanisms by which HHcy induces cardiac failure, focusing on NMDA-R1 activation.
  • To determine if blocking NMDA-R1 with dizocilpine (MK-801) can prevent or reverse HHcy-induced cardiac dysfunction.
  • To elucidate the role of mitochondrial dysfunction and E-M uncoupling in HHcy-related heart disease.

Main Methods:

  • Created chronic volume overload heart failure using aorta-venacava (AV) fistula in mice.
  • Induced HHcy by administering homocysteine in drinking water.
  • Administered MK-801 to block NMDA-R1, followed by EKG, echocardiography, and molecular analyses of cardiac tissue and endothelial cells.

Main Results:

  • HHcy and AVF induced systolic and diastolic heart failure, characterized by increased MMP-9, collagen degradation, and decreased elastin.
  • Mitochondrial dysfunction was evident with increased NOX4 and decreased peroxiredoxin.
  • MK-801 treatment significantly mitigated cardiac contractile dysfunction, suggesting NMDA-R1's critical role.

Conclusions:

  • HHcy exacerbates endothelial-myocyte uncoupling and cardiac failure, partly through NMDA-R1 activation.
  • Mitochondrial dysfunction and altered extracellular matrix contribute to HHcy-induced heart disease.
  • Targeting NMDA-R1 presents a potential therapeutic strategy for HHcy-related cardiac arrhythmias and sudden cardiac death.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
Dysrhythmias I: Introduction01:15

Dysrhythmias I: Introduction

Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...